publication date: Dec. 12, 2014

Varmus Discusses Grant Policy, Changes in Congress, & Ebola

 

 

NCI Director Harold Varmus addressed a joint meeting of the NCI Board of Scientific Advisors and the National Cancer Advisory Board Dec. 2, updating them on his proposed bypass budget for the institute, changes in Congressional leadership, and NCI and NIH grant policy.

He also took the time to congratulate NCI Deputy Director Douglas Lowy—who, along with colleague John Schiller, was honored by President Barack Obama with a National Medal of Technology and Innovation for their work on the HPV vaccine. The full story is available on p. 15.

Varmus also played a short video of President Franklin Delano Roosevelt dedicating Building One on the NIH campus in 1940, in an homage to Obama’s NIH visit that day regarding Ebola clinical trials and research funding.

His remarks to the joint BSA and NCAB meeting follow:

 

We only have 12 members of the NCAB; there is a slate that has not yet been endorsed by the White House. This is a serious problem to correct. And hopefully we’ll get the appointments through. 

Today’s agenda is long and complicated, in ways I’ll mention later, by the presidential visit. But there is a theme here today about presidents and the NIH and you will see more in just a moment. 

Today’s agenda is in four parts, roughly. We will have some promised follow-ups on the Center for Cancer Genomics and follow-up to our conversation a few meetings ago on e-cigarettes. We’ll talk about some grant policies, including K awards and modular grants. 

We have three RFAs for approval, shouldn’t take too … Continue reading 40-46 Varmus Discusses Grant Policy, Changes in Congress, & Ebola

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.